|
Market Closed -
Bombay S.E.
13:02:27 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 561.90 INR | +2.42% |
|
+2.86% | +28.14% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
| Market Cap | 2.01B 20.84M 18.6M 17.32M 15.77M 29.69M 29.91M 209M 81.44M 1.02B 78.25M 76.56M 3.29B | P/E 2025 |
10.4x | P/E 2026 | 8.08x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74B 18.11M 16.15M 15.05M 13.69M 25.79M 25.98M 182M 70.74M 890M 67.97M 66.5M 2.86B | EV / Sales 2025 |
1.94x | EV / Sales 2026 | 1.23x |
| Free-Float |
19.97% | Yield 2025 |
0.21% | Yield 2026 | 0.54% |
| 1 day | +2.42% | ||
| 1 week | +2.86% | ||
| Current month | -1.08% | ||
| 1 month | -2.11% | ||
| 3 months | -7.21% | ||
| 6 months | +43.00% | ||
| Current year | +28.14% |
| 1 week | 545.2 |  | 585 |
| 1 month | 534.65 | | 604.8 |
| Current year | 360 | | 679 |
| 1 year | 360 | | 679 |
| 3 years | 262.05 | | 999 |
| 5 years | 217 | | 999 |
| 10 years | 81.2 | | 1,190 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 26/05/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 26/05/2017 | |
| Director/Board Member | 49 | 26/05/2017 | |
Saurabh Shah
BRD | Director/Board Member | 40 | 28/05/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | +2.86% | +7.80% | +105.45% | 20.39M | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | |
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | |
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | |
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | |
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | |
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | |
| Average | +0.43% | -3.91% | +23.70% | +62.09% | 369.72B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.15B 11.94M 10.65M 9.92M 9.03M 17.01M 17.13M 120M 46.66M 587M 44.83M 43.86M 1.89B | 859M 8.92M 7.96M 7.41M 6.75M 12.7M 12.8M 89.57M 34.85M 438M 33.48M 32.76M 1.41B |
| Net income | 242M 2.51M 2.24M 2.08M 1.9M 3.57M 3.6M 25.19M 9.8M 123M 9.42M 9.21M 396M | 164M 1.7M 1.52M 1.41M 1.29M 2.42M 2.44M 17.08M 6.65M 83.61M 6.39M 6.25M 269M |
| Net Debt | -274M -2.84M -2.54M -2.36M -2.15M -4.05M -4.08M -28.56M -11.11M -140M -10.68M -10.45M -449M | -264M -2.74M -2.44M -2.28M -2.07M -3.9M -3.93M -27.5M -10.7M -135M -10.28M -10.06M -433M |
Employees
149
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | ₹561.90 | +2.42% | 599 |
| 01/10/26 | ₹548.60 | -3.42% | 871 |
| 30/09/26 | ₹568.05 | +4.23% | 1,435 |
| 29/09/26 | ₹545.00 | -0.23% | 713 |
- Stock Market
- Stocks
- CORALAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
